Cargando…
Trial Watch: Peptide vaccines in cancer therapy
Throughout the past 3 decades, along with the recognition that the immune system not only influences oncogenesis and tumor progression, but also determines how established neoplastic lesions respond therapy, renovated enthusiasm has gathered around the possibility of using vaccines as anticancer age...
Autores principales: | Aranda, Fernando, Vacchelli, Erika, Eggermont, Alexander, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902120/ https://www.ncbi.nlm.nih.gov/pubmed/24498550 http://dx.doi.org/10.4161/onci.26621 |
Ejemplares similares
-
Trial watch: Peptide vaccines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012) -
Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012) -
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012) -
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014)